Telemedicine and low-carb diet slashes diabetes meds and drives lasting remission

A five-year study on a low-carbohydrate, remote care intervention for type 2 diabetes shows significant improvements in diabetes remission, weight loss, and cardiometabolic health, reducing the need for medications.

Covid cut life expectancy by 1.6 years globally, but the leading causes of death haven’t changed since 1990

The leading causes of death haven’t changed since 1990 — with one glaring, pandemic-sized exception. According to the latest analysis of the Global Burden of

April 3, 2024

The contribution of transcription factor ROB1 to the pathophysiology of C. albicans-induced candidal infections

Researchers evaluated the function of the zinc finger transcription factor ROB1 and its two phenotypically distinct alleles in the pathogenesis of Candida albicans infections.

June 20, 2023

Merck and Eisai reveal late-stage fail for Keytruda and Lenvima in gastroesophageal cancer

The combination of Merck’s Keytruda and Eisai’s Lenvima failed to prolong patients’ lives versus the comparator in another cancer study, but the companies say they

January 25, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.